SO

Sobi
Latest price
445.80 SEK
17/09/2026
Latest (2)
570.62 SEK
+28.00%
Upside
Aligned
AVG (11)
550.00 SEK
+23.37%
Upside
Aligned
SOBI
3 mo+23.37%11 price targets
6 mo+15.52%13 price targets
1 yr+15.52%14 price targets
Max 21 price targets
HealthcareDrug Manufacturers—Specialty & Generic
Overview
Analysts
About The Company
Swedish Orphan Biovitrum (Sobi) is a pharmaceutical company with two focus areas: haemophilia and rare diseases. Sobi is a merger of Swedish Orphan and Biovitrum. The company has its premises in Karolinska Institutet Science Park in Solna.
Wikipedia
Latest Consensus
The average of the latest price targets from multiple analysts.
Consensus
570.62 SEK
Upside
+28.00%
Aligned2 houses · range 551.24 SEK–590.00 SEK
551.24 SEK590.00 SEK
line = latest price · dot = consensus
Latest price445.80 SEK
Three Month Consensus
The median of each house's latest target set within the last 90 days.
Consensus
550.00 SEK
Upside
+23.37%
Aligned11 houses · range 466.00 SEK–590.00 SEK · last 90 days
466.00 SEK590.00 SEK
line = latest price · dot = consensus
Latest price445.80 SEK
Insider Trades for Sobi
No insider trades for the selected period.